Currently, CAR-NK has been vigorously tested in breast cancer treatment targeting different breast cancer antigens including HER2 and EGFR, and EGFR-CAR-NK cells could be potentially used to treat patients with TNBC exhibiting enhanced EGFR expression (125). Here, EGFR is linked to breast carcinoma.